Canada markets closed

Milestone Pharmaceuticals Inc. (MIST)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
1.6900+0.0300 (+1.81%)
At close: 04:00PM EDT
1.6900 0.00 (0.00%)
After hours: 04:48PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
1,000
1,000
5,000
15,000
0
Operating Expenses
Research Development
31,052
31,052
39,829
38,671
34,488
Selling General and Administrative
31,046
31,046
24,813
19,402
16,222
Total Operating Expenses
62,098
62,098
64,642
58,073
50,710
Operating Income or Loss
-61,098
-61,098
-59,642
-43,073
-50,710
Interest Expense
2,554
2,554
0
-
-
Income Before Tax
-59,685
-59,685
-58,388
-42,853
-49,984
Income Tax Expense
-
-
-
0
-17
Income from Continuing Operations
-59,685
-59,685
-58,388
-42,853
-49,967
Net Income
-59,685
-59,685
-58,388
-42,853
-49,967
Net Income available to common shareholders
-59,685
-59,685
-58,388
-42,853
-49,967
Basic EPS
-1.38
-
-1.38
-1.02
-1.70
Diluted EPS
-1.38
-
-1.38
-1.02
-1.70
Basic Average Shares
42,886
-
42,450
41,834
29,345
Diluted Average Shares
42,886
-
42,450
41,834
29,345